Find whatever's trending in Punjab, India and the world on True Scoop News. From Breaking news to analysis of the trending topics, True Scoop covers it all

dcgi

The expert panel suggested the phase two and three trials which now will be carried out on 525 healthy volunteers.

Covaxin receives green flag for Phase 2/3 clinical trials on 2-18 age group

AstraZeneca is currently working with the Russians on the combination of their vaccine's vector with that from Sputnik V, precisely to see if that could help boost its vaccine's efficacy to over 90 per cent as well.

Sputnik V working to take AstraZeneca Covid-19 vaccine efficacy to over 90 percent

His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZenca and Oxford. Poonawalla added the vaccine is safe, effective and ready for rollout.

India's first Covid-19 vaccine ‘Covishield’ will roll out in coming weeks

This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.

DCGI approves Serum Institute’s ‘Covishield’ & Bharat Biotech's 'Covaxin' for emergency use

The declaration by the Pune-based vaccine manufacturer came a day after the Drug Control General of India (DCGI), V.G. Somani, issued a show-cause notice

Update! DCGI directs Serum Institute to put AstraZeneca Covid vaccine trials in India on hold

The SII received approval by the India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.

News

Covaxin receives green flag for Phase 2/3 clinical trials on 2-18 age group

Sputnik V working to take AstraZeneca Covid-19 vaccine efficacy to over 90 percent

India's first Covid-19 vaccine ‘Covishield’ will roll out in coming weeks

DCGI approves Serum Institute’s ‘Covishield’ & Bharat Biotech's 'Covaxin' for emergency use

Update! DCGI directs Serum Institute to put AstraZeneca Covid vaccine trials in India on hold

DCGI approves SII's clinical trials of Oxford vaccine